Hunt J M, Buckley M T, Laishes B A, Dunsford H A
Cancer Res. 1985 May;45(5):2226-33.
Surface-localized rat RT1 alloantigens on isolated hepatocytes have been used to achieve partial purification of putative premalignant liver cells from rats undergoing chemically induced hepatocarcinogenesis. Genotypic mosaic rat livers were constructed by transplantation of carcinogen-altered F-344 (RT1Iv1) or WF (RT1u) donor liver cells into livers of WF X F-344 F1 host rats, whose liver cells bear alloantigens of both parental strains: WF and F-344, RT1u and RT1Iv1, respectively (J. M. Hunt et al., Cancer Res., 42: 227-236, 1982). Donor and host origin hepatocytes were thus distinguishable immunologically with anti-RT1u or anti-RT1Iv1 alloantisera. Donor rats were treated with diethylnitrosamine (200 mg/kg i.p.) followed by an experimental regimen of dietary 2-acetylaminofluorene and partial hepatectomy. Standard host rats received only the 2-acetylaminofluorene-partial hepatectomy regimen. At 10 to 21 days after transplantation, mosaic host rat livers typically contained 7% donor origin hepatocytes, 96% of which were positive histochemically for gamma-glutamyl transpeptidase. Host origin hepatocytes could be effectively purified by affinity chromatography ("panning") of isolated hepatocytes. To obtain donor origin hepatocytes, the putative progenitor cells of liver carcinomas in these mosaic livers, two approaches were used. Alloantibody-mediated rosette formation followed by sedimentation through Ficoll/metrizamide resulted in a 4- to 10-fold enrichment for donor origin hepatocytes isolated from mosaic livers. Similarly, a 5- to 11-fold enrichment for donor origin hepatocytes was achieved by specific alloantibody-mediated cytolysis of host hepatocytes with rabbit complement followed by purification of viable donor origin cells by sedimentation on metrizamide cushions. Hepatocellular carcinomas which developed in the genotypic mosaic host rat livers were excised 17 to 21 months after donor liver cell transplantation and passaged s.c. or i.m. in histocompatible rats. The transplantable tumors were typed for strain of origin by indirect immunofluorescence using rat alloantisera, and five of six tumors displayed antigenicity reflecting donor strain origin. We conclude, therefore, that the transplanted donor liver cell populations contain cellular precursors of hepatocellular carcinomas which may be isolable using combinations of the purification strategies described.
已利用分离肝细胞表面定位的大鼠RT1同种异体抗原,从经历化学诱导肝癌发生的大鼠中部分纯化假定的癌前肝细胞。通过将致癌物改变的F-344(RT1Iv1)或WF(RT1u)供体肝细胞移植到WF×F-344 F1宿主大鼠的肝脏中构建基因型嵌合大鼠肝脏,其肝细胞分别带有两个亲本品系的同种异体抗原:WF和F-344、RT1u和RT1Iv1(J.M.亨特等人,《癌症研究》,42:227 - 236,1982)。因此,供体和宿主来源的肝细胞可用抗RT1u或抗RT1Iv1同种抗血清进行免疫区分。给供体大鼠腹腔注射二乙基亚硝胺(200mg/kg),随后采用含2 - 乙酰氨基芴的饮食和部分肝切除术的实验方案。标准宿主大鼠仅接受2 - 乙酰氨基芴 - 部分肝切除术方案。移植后10至21天,嵌合宿主大鼠肝脏通常含有7%的供体来源肝细胞,其中96%的细胞γ-谷氨酰转肽酶组织化学染色呈阳性。宿主来源的肝细胞可通过对分离的肝细胞进行亲和层析(“淘选”)有效纯化。为了获得这些嵌合肝脏中肝癌的假定祖细胞即供体来源的肝细胞,采用了两种方法。同种抗体介导的玫瑰花结形成,随后通过Ficoll/甲泛影酰胺沉降,可使从嵌合肝脏中分离的供体来源肝细胞富集4至10倍。同样,通过用兔补体对宿主肝细胞进行特异性同种抗体介导的细胞溶解,随后在甲泛影酰胺垫层上沉降纯化存活的供体来源细胞,可使供体来源肝细胞富集5至11倍。在基因型嵌合宿主大鼠肝脏中发生的肝细胞癌在供体肝细胞移植后17至21个月切除,并在组织相容性大鼠中皮下或肌肉传代。使用大鼠同种抗血清通过间接免疫荧光对可移植肿瘤进行起源品系分型,六个肿瘤中有五个显示出反映供体品系起源的抗原性。因此,我们得出结论,移植的供体肝细胞群体包含肝细胞癌的细胞前体,可使用所述纯化策略的组合将其分离出来。